As the CXCR4–CXCL12–CXCR7 axis and the mTOR pathway were described to regulate cell growth in renal cancer, we wished to evaluate whether targeting the two pathways might affect cell proliferation of SN12C and A498. This evidence concerns the gene CXCR4 and renal carcinoma.